345 related articles for article (PubMed ID: 29558367)
1. HMGB1 links chronic liver injury to progenitor responses and hepatocarcinogenesis.
Hernandez C; Huebener P; Pradere JP; Antoine DJ; Friedman RA; Schwabe RF
J Clin Invest; 2018 Jun; 128(6):2436-2451. PubMed ID: 29558367
[TBL] [Abstract][Full Text] [Related]
2. HMGB1 promotes ductular reaction and tumorigenesis in autophagy-deficient livers.
Khambu B; Huda N; Chen X; Antoine DJ; Li Y; Dai G; Köhler UA; Zong WX; Waguri S; Werner S; Oury TD; Dong Z; Yin XM
J Clin Invest; 2018 Jun; 128(6):2419-2435. PubMed ID: 29558368
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-Mediated Regulation of HMGB1 in Human Hepatocellular Carcinoma.
Yan J; Ying S; Cai X
Biomed Res Int; 2018; 2018():2754941. PubMed ID: 29651425
[TBL] [Abstract][Full Text] [Related]
4. Clinical Implication of the Relationship Between High Mobility Group Box-1 and Tumor Differentiation in Hepatocellular Carcinoma.
Ando K; Sakoda M; Ueno S; Hiwatashi K; Iino S; Minami K; Kawasaki Y; Hashiguchi M; Tanoue K; Mataki Y; Kurahara H; Maemura K; Shinchi H; Natsugoe S
Anticancer Res; 2018 Jun; 38(6):3411-3418. PubMed ID: 29848691
[TBL] [Abstract][Full Text] [Related]
5. Liver stem cells: implications for hepatocarcinogenesis.
Alison MR
Stem Cell Rev; 2005; 1(3):253-60. PubMed ID: 17142862
[TBL] [Abstract][Full Text] [Related]
6. Haematopoietic cell-derived Jnk1 is crucial for chronic inflammation and carcinogenesis in an experimental model of liver injury.
Cubero FJ; Zhao G; Nevzorova YA; Hatting M; Al Masaoudi M; Verdier J; Peng J; Schaefer FM; Hermanns N; Boekschoten MV; Grouls C; Gassler N; Kiessling F; Muller M; Davis RJ; Liedtke C; Trautwein C
J Hepatol; 2015 Jan; 62(1):140-9. PubMed ID: 25173965
[TBL] [Abstract][Full Text] [Related]
7. High-Mobility Group Box 1 Promotes Hepatocellular Carcinoma Progression through miR-21-Mediated Matrix Metalloproteinase Activity.
Chen M; Liu Y; Varley P; Chang Y; He XX; Huang H; Tang D; Lotze MT; Lin J; Tsung A
Cancer Res; 2015 Apr; 75(8):1645-56. PubMed ID: 25720799
[TBL] [Abstract][Full Text] [Related]
8. Targeted deletion of ER chaperone GRP94 in the liver results in injury, repopulation of GRP94-positive hepatocytes, and spontaneous hepatocellular carcinoma development in aged mice.
Chen WT; Ha D; Kanel G; Lee AS
Neoplasia; 2014 Aug; 16(8):617-26. PubMed ID: 25220589
[TBL] [Abstract][Full Text] [Related]
9. Loss of Dicer1 impairs hepatocyte survival and leads to chronic inflammation and progenitor cell activation.
Lu XF; Zhou YJ; Zhang L; Ji HJ; Li L; Shi YJ; Bu H
World J Gastroenterol; 2015 Jun; 21(21):6591-603. PubMed ID: 26074697
[TBL] [Abstract][Full Text] [Related]
10. The contribution of toll-like receptor signaling to the development of liver fibrosis and cancer in hepatocyte-specific TAK1-deleted mice.
Song IJ; Yang YM; Inokuchi-Shimizu S; Roh YS; Yang L; Seki E
Int J Cancer; 2018 Jan; 142(1):81-91. PubMed ID: 28875549
[TBL] [Abstract][Full Text] [Related]
11. Proliferating EpCAM-Positive Ductal Cells in the Inflamed Liver Give Rise to Hepatocellular Carcinoma.
Matsumoto T; Takai A; Eso Y; Kinoshita K; Manabe T; Seno H; Chiba T; Marusawa H
Cancer Res; 2017 Nov; 77(22):6131-6143. PubMed ID: 28951464
[TBL] [Abstract][Full Text] [Related]
12. Hypoxia mediates mitochondrial biogenesis in hepatocellular carcinoma to promote tumor growth through HMGB1 and TLR9 interaction.
Tohme S; Yazdani HO; Liu Y; Loughran P; van der Windt DJ; Huang H; Simmons RL; Shiva S; Tai S; Tsung A
Hepatology; 2017 Jul; 66(1):182-197. PubMed ID: 28370295
[TBL] [Abstract][Full Text] [Related]
13. High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.
Zhang QB; Jia QA; Wang H; Hu CX; Sun D; Jiang RD; Zhang ZL
BMC Cancer; 2016 Nov; 16(1):880. PubMed ID: 27836008
[TBL] [Abstract][Full Text] [Related]
14. The Role of HMGB1 Signaling Pathway in the Development and Progression of Hepatocellular Carcinoma: A Review.
Wang X; Xiang L; Li H; Chen P; Feng Y; Zhang J; Yang N; Li F; Wang Y; Zhang Q; Li F; Cao F
Int J Mol Sci; 2015 Sep; 16(9):22527-40. PubMed ID: 26393575
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through Toll-like receptor 9.
Liu Y; Yan W; Tohme S; Chen M; Fu Y; Tian D; Lotze M; Tang D; Tsung A
J Hepatol; 2015 Jul; 63(1):114-21. PubMed ID: 25681553
[TBL] [Abstract][Full Text] [Related]
16. Caspase-3 suppresses diethylnitrosamine-induced hepatocyte death, compensatory proliferation and hepatocarcinogenesis through inhibiting p38 activation.
Shang N; Bank T; Ding X; Breslin P; Li J; Shi B; Qiu W
Cell Death Dis; 2018 May; 9(5):558. PubMed ID: 29752472
[TBL] [Abstract][Full Text] [Related]
17. Ablation of high-mobility group box-1 in the liver reduces hepatocellular carcinoma but causes hyperbilirubinemia in Hippo signaling-deficient mice.
Athavale D; Song Z; Desert R; Han H; Das S; Ge X; Komakula SSB; Chen W; Gao S; Lantvit D; Guzman G; Nieto N
Hepatol Commun; 2022 Aug; 6(8):2155-2169. PubMed ID: 35344292
[TBL] [Abstract][Full Text] [Related]
18. Receptor for advanced glycation endproducts (RAGE) is a key regulator of oval cell activation and inflammation-associated liver carcinogenesis in mice.
Pusterla T; Nèmeth J; Stein I; Wiechert L; Knigin D; Marhenke S; Longerich T; Kumar V; Arnold B; Vogel A; Bierhaus A; Pikarsky E; Hess J; Angel P
Hepatology; 2013 Jul; 58(1):363-73. PubMed ID: 23504974
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma.
Ning BF; Ding J; Yin C; Zhong W; Wu K; Zeng X; Yang W; Chen YX; Zhang JP; Zhang X; Wang HY; Xie WF
Cancer Res; 2010 Oct; 70(19):7640-51. PubMed ID: 20876809
[TBL] [Abstract][Full Text] [Related]
20. Hepatocyte autotaxin expression promotes liver fibrosis and cancer.
Kaffe E; Katsifa A; Xylourgidis N; Ninou I; Zannikou M; Harokopos V; Foka P; Dimitriadis A; Evangelou K; Moulas AN; Georgopoulou U; Gorgoulis VG; Dalekos GN; Aidinis V
Hepatology; 2017 Apr; 65(4):1369-1383. PubMed ID: 27981605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
